The DOI matches its Crossref record; 175 of the 175 references it cites were found in a registry or an index.
Diabetic ketoacidosis and hyperglycemic hyperosmolar state
Open accessAbstract
This article is a chapter in the ISPAD Clinical Practice Consensus Guidelines 2014 Compendium.The complete set of guidelines can be found for free download at www.ispad.org.The evidence grading system used in the ISPAD Guidelines is the same as that used by the American Diabetes Association.See page 3 (the Introduction in Pediatric Diabetes 2014; 15 (Suppl.20): 1-3). Diabetic ketoacidosis and hyperglycemic hyperosmolar stateRisk factors for DKA in patients with known diabetes include insulin omission, poor metabolic control, previous episodes of DKA, gastroenteritis with persistent vomiting and inability to maintain hydration, psychiatric (including eating) disorders, challenging social and family circumstances, peripubertal and adolescent girls, limited access to medical services, failures in insulin pump therapy.The following recommendations are based on currently available evidence and are intended only as a general guide to DKA management.Because there is considerable individual variability in presentation of DKA (ranging from mild with only minimal dehydration to severe with profound dehydration), some patients may require specific treatment that, in the judgment of the treating physician, may be within or, occasionally, outside the range of options presented here.Clinical judgment should always be used to determine optimal treatment of the individual patient, and timely adjustments to treatment (insulin dose, electrolyte composition and rate of infusion of rehydration fluids) should be based on ongoing, careful clinical and biochemical monitoring of the patient's response.Emergency assessment should follow the general guidelines for Pediatric Advanced Life Support (PALS) and includes: immediate measurement of BG, blood or urine ketones, serum electrolytes, blood gases and full blood count; assessment of severity of dehydration and level of consciousness (E).A second peripheral IV catheter should be inserted (E).Management should be in centers experienced in the treatment of DKA in children and adolescents and where vital signs, neurological status and laboratory results can be monitored frequently (E).Where geographic constraints require that management be initiated in a center with less experience and with fewer resources, there should be arrangements in place for telephone or videoconference support from a physician with expertise in DKA (E).Meticulous monitoring of the clinical and biochemical response to treatment is necessary so that timely adjustments in treatment can be made when indicated by the patient's clinical or laboratory data (E).Goals of therapy are to correct dehydration, correct acidosis and reverse ketosis, slowly correct hyperosmolality and restore BG to near normal, monitor for complications of DKA and its treatment, and identify and treat any precipitating event.Fluid replacement should begin before starting insulin therapy.Expand volume, as required, to restore peripheral circulation (E).Calculate the subsequent rate of fluid administration, including the provision of maintenance fluid requirements, aiming to replace the estimated fluid deficit evenly over 48 h.The rate of fluid administration should
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
ASSESSMENT OF COMA AND IMPAIRED CONSCIOUSNESS
Teasdale, G., & Jennett, B. (1974) · The Lancet · doi:10.1016/s0140-6736(74)91639-0 · Cited by 13,215
Kleinman, M. E., Chameides, L., Schexnayder, S. M., Samson, R. A., Hazinski, M. F., Atkins, D. L., Berg, M. D., de Caen, A. R., Fink, E. L., Freid, E. B., et al. (2010) · Circulation · doi:10.1161/circulationaha.110.971101 · Cited by 1,949
THE MAINTENANCE NEED FOR WATER IN PARENTERAL FLUID THERAPY
Holliday, M. A., & Segar, W. E. (1957) · Pediatrics · doi:10.1542/peds.19.5.823 · Cited by 981
Type 2 diabetes in children and adolescents. American Diabetes Association.
(2000) · Diabetes Care · doi:10.2337/diacare.23.3.381 · Cited by 936
Risk Factors for Cerebral Edema in Children with Diabetic Ketoacidosis
Glaser, N., Barnett, P., McCaslin, I., Nelson, D., Trainor, J., Louie, J., Kaufman, F., Quayle, K., Roback, M., Malley, R., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200101253440404 · Cited by 779
Self-citationTERSMETTE, M. (1989) · The Lancet · doi:10.1016/s0140-6736(89)92628-7 · Cited by 575
The Pathophysiology and Clinical Characteristics of Severe Hypophosphatemia
Knochel, J. P. (1977) · Archives of Internal Medicine · doi:10.1001/archinte.1977.03630140051013 · Cited by 568
Hyponatremia: evaluating the correction factor for hyperglycemia
Hillier, T. A., Abbott, R. D., & Barrett, E. J. (1999) · The American Journal of Medicine · doi:10.1016/s0002-9343(99)00055-8 · Cited by 567
Risk Factors for Cerebral Edema in Children with Diabetic Ketoacidosis
(2001) · New England Journal of Medicine · doi:10.1056/nejm200105173442014 · Cited by 533
Hyperglycemia-Induced Hyponatremia — Calculation of Expected Serum Sodium Depression
Katz, M. A. (1973) · New England Journal of Medicine · doi:10.1056/nejm197310182891607 · Cited by 524
Cited by
Atkinson, M. A., Eisenbarth, G. S., & Michels, A. W. (2014) · The Lancet · doi:10.1016/s0140-6736(13)60591-7 · Cited by 2,931
Japanese clinical practice guideline for diabetes 2019
Araki, E., Goto, A., Kondo, T., Noda, M., Noto, H., Origasa, H., Osawa, H., Taguchi, A., Tanizawa, Y., Tobe, K., et al. (2020) · Diabetology International · doi:10.1007/s13340-020-00439-5 · Cited by 545
Chiang, J. L., Maahs, D. M., Garvey, K. C., Hood, K. K., Laffel, L. M., Weinzimer, S. A., Wolfsdorf, J. I., & Schatz, D. (2018) · Diabetes Care · doi:10.2337/dci18-0023 · Cited by 509
Self-citationDhatariya, K. K., Glaser, N. S., Codner, E., & Umpierrez, G. E. (2020) · Nature Reviews Disease Primers · doi:10.1038/s41572-020-0165-1 · Cited by 461
Self-citationKarges, B., Schwandt, A., Heidtmann, B., Kordonouri, O., Binder, E., Schierloh, U., Boettcher, C., Kapellen, T., Rosenbauer, J., & Holl, R. W. (2017) · JAMA · doi:10.1001/jama.2017.13994 · Cited by 452
Japanese Clinical Practice Guideline for Diabetes 2019
Araki, E., Goto, A., Kondo, T., Noda, M., Noto, H., Origasa, H., Osawa, H., Taguchi, A., Tanizawa, Y., Tobe, K., et al. (2020) · Journal of Diabetes Investigation · doi:10.1111/jdi.13306 · Cited by 341
Zucchini, S., Scaramuzza, A. E., Bonfanti, R., Buono, P., Cardella, F., Cauvin, V., Cherubini, V., Chiari, G., d’Annunzio, G., Frongia, A. P., et al. (2016) · Journal of Diabetes Research · doi:10.1155/2016/5719470 · Cited by 326
Incidence of type 1 diabetes in China, 2010-13: population based study
Weng, J., Zhou, Z., Guo, L., Zhu, D., Ji, L., Luo, X., Mu, Y., & Jia, W. (2018) · BMJ · doi:10.1136/bmj.j5295 · Cited by 316
Yield of a public health screening of children for islet autoantibodies in Bavaria, Germany
Ziegler, A.-G., Kick, K., Bonifacio, E., Haupt, F., Hippich, M., Dunstheimer, D., Lang, M., Laub, O., Warncke, K., Lange, K., et al. (2020) · JAMA · doi:10.1001/jama.2019.21565 · Cited by 312
Hyperglycemic crises in adults with diabetes: a consensus report
Umpierrez, G. E., Davis, G. M., ElSayed, N. A., Fadini, G. P., Galindo, R. J., Hirsch, I. B., Klonoff, D. C., McCoy, R. G., Misra, S., Gabbay, R. A., et al. (2024) · Diabetes Care · doi:10.2337/dci24-0032 · Cited by 278
Maahs, D. M., Hermann, J. M., Holman, N., Foster, N. C., Kapellen, T. M., Allgrove, J., Schatz, D. A., Hofer, S. E., Campbell, F., Steigleder-Schweiger, C., et al. (2015) · Diabetes Care · doi:10.2337/dc15-0780 · Cited by 224
Self-citationISPAD Clinical Practice Consensus Guidelines 2018: diabetes technologies
Sherr, J. L., Tauschmann, M., Battelino, T., de Bock, M., Forlenza, G., Roman, R., Hood, K. K., & Maahs, D. M. (2018) · Pediatric Diabetes · doi:10.1111/pedi.12731 · Cited by 197
Jensen, E. T., Stafford, J. M., Saydah, S., D’Agostino, R. B., Dolan, L. M., Lawrence, J. M., Marcovina, S., Mayer-Davis, E. J., Pihoker, C., Rewers, A., et al. (2021) · Diabetes Care · doi:10.2337/dc20-0389 · Cited by 137
Karges, B., Rosenbauer, J., Holterhus, P.-M., Beyer, P., Seithe, H., Vogel, C., Böckmann, A., Peters, D., Müther, S., Neu, A., et al. (2015) · European Journal of Endocrinology · doi:10.1530/eje-15-0129 · Cited by 129
Diabetic ketoacidosis at diagnosis of type 1 diabetes in Colorado children, 2010-2017
Alonso, G. T., Coakley, A., Pyle, L., Manseau, K., Thomas, S., & Rewers, A. (2020) · Diabetes Care · doi:10.2337/dc19-0428 · Cited by 117
Managing diabetes in preschool children
Sundberg, F., Barnard, K., Cato, A., de Beaufort, C., DiMeglio, L. A., Dooley, G., Hershey, T., Hitchcock, J., Jain, V., Weissberg-Benchell, J., et al. (2017) · Pediatric Diabetes · doi:10.1111/pedi.12554 · Cited by 91
Self-citationThalange, N., Deeb, L., Iotova, V., Kawamura, T., Klingensmith, G., Philotheou, A., Silverstein, J., Tumini, S., Ocampo Francisco, A., Kinduryte, O., et al. (2015) · Pediatric Diabetes · doi:10.1111/pedi.12263 · Cited by 91
Insulin Infusion Set Use: European Perspectives and Recommendations
Deiss, D., Adolfsson, P., Alkemade-van Zomeren, M., Bolli, G. B., Charpentier, G., Cobelli, C., Danne, T., Girelli, A., Mueller, H., Verderese, C. A., et al. (2016) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2016.07281.sf · Cited by 62
Harrison, V. S., Rustico, S., Palladino, A. A., Ferrara, C., & Hawkes, C. P. (2017) · Pediatric Diabetes · doi:10.1111/pedi.12462 · Cited by 43
Diabetic Ketoacidosis: A Review and Update
Perilli, G., Saraceni, C., Daniels, M. N., & Ahmad, A. (2013) · Current Emergency and Hospital Medicine Reports · doi:10.1007/s40138-012-0001-3 · Cited by 34
Bratke, H., Margeirsdottir, H. D., Assmus, J., Njølstad, P. R., & Skrivarhaug, T. (2021) · Diabetes Therapy · doi:10.1007/s13300-021-01127-6 · Cited by 20
Macek, J., Battelino, T., Bizjak, M., Zupanc, C., Bograf, A. K., Vesnic, S., Klemencic, S., Volk, E., & Bratina, N. (2019) · Journal of Psychosomatic Research · doi:10.1016/j.jpsychores.2019.109816 · Cited by 16
Time trend in excess mortality in children with type 1 diabetes from 1987 to 2016 in mainland France
Donzeau, A., Piffaretti, C., Jossens, A., Levaillant, L., Bouhours‐Nouet, N., Amsellem‐Jager, J., Ghosn, W., Rey, G., Fosse‐Edorh, S., & Coutant, R. (2022) · Pediatric Diabetes · doi:10.1111/pedi.13298 · Cited by 15
Wadwa, R. P., Chase, H. P., Raghinaru, D., Buckingham, B. A., Hramiak, I., Maahs, D. M., Messer, L., Ly, T., Aye, T., Clinton, P., et al. (2017) · Pediatric Diabetes · doi:10.1111/pedi.12410 · Cited by 13
Thalange, N., Gundgaard, J., Parekh, W., & Tutkunkardas, D. (2019) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2019-000664 · Cited by 7
Metadata
- Authors
- Wolfsdorf, J. I., Allgrove, J., Craig, M. E., Edge, J., Glaser, N., Jain, V., Lee, W. W., Mungai, L. N., Rosenbloom, A. L., Sperling, M. A., & Hanas, R.
- Venue
- Pediatric Diabetes
- Publisher
- Wiley
- Published
- 2014-07-12
- Volume
- 15
- Issue
- S20
- Pages
- 154-179
- ISSN
- 1399-543X (ISSN-L)
- OpenAlex
- W2131462635
- Cited by
- 371
- References
- 175
- FWCI
- 28.00
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.